Investor Snapshot

Sienna identifies, develops and commercialises reagents and in vitro diagnostic tests that target an unmet need. Sienna has built a strong team and a global scientific, clinical, and commercial partner network.

Sienna's first technology platform for the detection of telomerase, has been validated through it's adoption and use at major USA pathology laboratories. 

Current work programs are focussed on:

  • Market penetration of the telomerase technology platform in current IVD registered markets
  • Global market expansion for existing product
  • Scientific R&D both internal and through global partners to research expanded utility of telomerase product 
  • The search for additional biomarkers to feed the Sienna development and commercialisation engine    


Name Sienna Cancer Diagnostics Ltd. (ASX: SDX)
Business Description Sienna is a medical technology company that develops and commercialises in-vitro diagnostic products for the pathology market.
History Originally incorporated in Sydney, the Company is now headquartered on the outskirts of Melbourne in a business park alongside many other medical technology companies, both large and small. A public unlisted company until August 2017, Sienna started trading on the ASX as a public listed company on August 3rd, 2017.
Shares on issue Approximately 180 million
Share price at last capital raising $0.20 as part of the Initial Public Offer
Company structure  Public listed company 
Location  Head office and laboratory based at the Small Technologies Cluster, 1 Dalmore Drive, Scoresby, VIC 3179, Australia 
Auditor  Walker Wayland NSW
Chartered Accountants
8th Floor, 55 Hunter St
Sydney, NSW 2000 Australia Tel: +61-2- 9951-5400
Corporate Advisor

Matthew Lindh
Harbury Capital
+61 432 363 933

Company Secretary  Tony Di Pietro 
+61 (3) 8288 2141
Share Registry 

Link Market Services
Locked Bag A14
Sydney South, NSW 1235

Toll-free: 1300-554-474 (Australia only)
International: +61-1300-554-474

Investor Documents

Annual Reports are prepared by Sienna and its auditors under Corporations Law each year for the financial year July-June. Copies of annual reports can be viewed here or provided as hard copy if requested at

  • Annual Report to June 2018
  • Appendix 4C - 30 March 2018
  • Appendix 4D and Half-Year Financial Report - 31 Dec 2017
  • Appendix 4C - 31 Dec 2017
  • Annual report to June 2017
  • SDX Appendix 4E & 2017 Financial Report
  • Sienna Prospectus
  • Annual report to June 2016
  • Sienna 2015 AGM Resolutions
  • Annual report to June 2015
  • Company constitution 2015
  • Annual report to June 2014
  • Annual report to June 2013
  • Annual report to June 2012
  • Annual report to June 2011
  • Chinese language company overview
  • Collection and Privacy Policy Collection and Privacy Policy (339 KB)

     Collection and Privacy Policy

Sign up for updates